China making big gains in drug R&D jobs state covets
The total annual cost for one researcher at Lilly might run $300,000 to $350,000 a year. The figure at Crown Bioscience is one-third of that, said a company executive.
The total annual cost for one researcher at Lilly might run $300,000 to $350,000 a year. The figure at Crown Bioscience is one-third of that, said a company executive.
All publicly traded companies have to allow advisory votes about top executives compensation every two or three under the Dodd-Frank financial reform passed by Congress last year.
Being an accountable care organization will be the major leagues of health care after the federal Medicare program set a high bar for the new kind of doctor-hospital organization.
Physicians are regarded as smart, successful and helpful when you’re sick—but not usually as a big driver of the economy. Now, however, physician trade groups are arguing that docs are good for business too.
Northern Indiana's Manchester College plans to begin work this summer on the college's new $18 million pharmacy school.
The widespread Internet posting of a letter by a retired Purdue University researcher who says he has linked genetically modified corn and soybeans to crop diseases and to abortions and infertility in livestock has raised concern among scientists that the public will believe his unsupported claim is true.
Eli Lilly and Co. is starting a service program that sends employees around the world to help developing communities and learn about other cultures, as the drugmaker looks to international markets.
A new report says Hamilton and Boone counties are among the healthiest in Indiana, while Marion ranks among the worst.
The Mishawaka-based Franciscan Alliance plans to spend $8.4 million to open an administrative center in Greenwood, creating 84 jobs in the next four years.
Tom Swoik, executive director of Illinois Casino Gaming Association, said gambling revenue has dropped 32 percent since the state’s smoking ban was approved. He said the ban has cost state government about $800 million in taxes.
Susan Rider is an employee-benefits account manager at Indianapolis-based Gregory & Appel Insurance. On July 1, she will become president of the Indiana State Association of Health Underwriters. She spoke about the first-year impact of the 2010 health reform law and further changes to come.
The Warsaw-based maker of orthopedic implants has filed suit to stop a Detroit-area law firm from making allegedly false claims and using its trademarks on websites designed to attract plaintiffs to sue Zimmer over one of its knee-replacement implants called NexGen.
Health reform will make health insurance a less-profitable business, but WellPoint Inc. got a vote of confidence from bond analysts because health-reform rules have turned out milder than expected and WellPoint’s financial performance has been particularly strong as the economy recovers.
The founder of Bloomington-based life sciences giant Cook Group Inc. and the wealthiest man in Indiana leaves a legacy of dozens of historic structures saved from decay or demolition. He also was a major donor to Indiana University and its athletics department.
Premiums for private health insurers in China are expected to rise to $90 billion by 2020 from $9 billion now, and WellPoint Inc. is angling for a big piece of that pie.
China remains a small market for Eli Lilly and Co. It generated $320 million in sales for the company in 2010, just 1.3 percent of its $23 billion in sales worldwide. But Lilly has big ambitions in China and is racing to capitalize on its rapid economic growth.
With economic growth in the United States sluggish, Indiana companies are joining the race to capitalize on the fast-growing Chinese economy—even as hundreds of millions of Chinese move into the middle class and adopt a Western-style thirst for goods and services.
Indiana University Health has canceled its plans for a $73 million administrative office building at 16th Street and Capitol Avenue and has instead purchased the Gateway Plaza tower at 10th and Illinois streets.
It was a good but not great year financially for three of the four largest hospital systems operating in the Indianapolis area last year—and hospital analysts are expecting several head winds to continue.
One year after President Obama signed the health reform overhaul, health insurers are buying less-regulated companies in a bid to offset the lower profits and growth they expect the law to cause.